文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

St. Charlesh Hospital, London, U.K.

Prog Neuropsychopharmacol Biol Psychiatry. 1992 Jan;16(1):17-26. doi: 10.1016/0278-5846(92)90004-x.

Although there is clear evidence for many controlled trials in the past 25 years that beta blockers are effective in anxiety disorders clear indications for their use are lacking. 2. The balance of evidence suggests that the mechanism of action of beta-blocking drugs is through peripheral blockade of beta-mediated symptoms. 3. Most evidence to the efficacy of beta-blockers comes from study of their use in generalized anxiety and in acute stress. 4. Because beta-blockers carry no risks of pharmacological dependence they may be preferred to many other anti-anxiety drugs.

尽管在过去25年中有许多对照试验明确证明β受体阻滞剂对焦虑症有效，但仍缺乏其使用的明确指征。2. 证据表明，β受体阻滞剂的作用机制是通过外周阻断β介导的症状。3. 关于β受体阻滞剂疗效的大多数证据来自对其在广泛性焦虑和急性应激中的应用研究。4. 由于β受体阻滞剂不存在药物依赖风险，与许多其他抗焦虑药物相比，它们可能更受青睐。

St. Charlesh Hospital, London, U.K.

Prog Neuropsychopharmacol Biol Psychiatry. 1992 Jan;16(1):17-26. doi: 10.1016/0278-5846(92)90004-x.

Although there is clear evidence for many controlled trials in the past 25 years that beta blockers are effective in anxiety disorders clear indications for their use are lacking. 2. The balance of evidence suggests that the mechanism of action of beta-blocking drugs is through peripheral blockade of beta-mediated symptoms. 3. Most evidence to the efficacy of beta-blockers comes from study of their use in generalized anxiety and in acute stress. 4. Because beta-blockers carry no risks of pharmacological dependence they may be preferred to many other anti-anxiety drugs.

尽管在过去25年中有许多对照试验明确证明β受体阻滞剂对焦虑症有效，但仍缺乏其使用的明确指征。2. 证据表明，β受体阻滞剂的作用机制是通过外周阻断β介导的症状。3. 关于β受体阻滞剂疗效的大多数证据来自对其在广泛性焦虑和急性应激中的应用研究。4. 由于β受体阻滞剂不存在药物依赖风险，与许多其他抗焦虑药物相比，它们可能更受青睐。